Curcumin-Based Nanomedicines as Cancer Therapeutics 1st Edition

Curcumin-Based Nanomedicines as Cancer Therapeutics, 1st Edition by Amirhossein Sahebkar and Prashant Kesharwani delivers a cutting-edge exploration of how curcumin — the potent natural compound from turmeric — is being reinvented through nanotechnology to tackle cancer. This authoritative volume captures attention with its timely focus on improving curcumin’s bioavailability, specificity, and therapeutic index using advanced nanoparticle platforms.

Dive into a richly detailed resource that maps the latest nanoparticulate delivery systems, formulation strategies, pharmacokinetics, and preclinical/clinical translation pathways. Written for oncologists, pharmaceutical scientists, researchers, and graduate students, the text balances rigorous science with practical insights: from liposomes, polymeric nanoparticles, and solid lipid carriers to targeted and stimuli-responsive systems that enhance tumor uptake and reduce systemic toxicity.

Imagine bridging bench-to-bedside possibilities: the book outlines experimental design, safety profiling, and regulatory considerations necessary to advance curcumin-based nanomedicines toward clinical application. Readers gain actionable knowledge to guide formulation development, in vivo evaluation, and translational studies — making it an indispensable reference for those focused on oncology therapeutics, nanomedicine, and natural-product drug development.

Whether you’re in North America, Europe, India, or elsewhere, this international, peer-informed text equips researchers and clinicians with the latest insights to push cancer therapeutics forward. Compact yet comprehensive, it’s an essential addition to professional and academic libraries.

Order your copy today to stay at the forefront of curcumin nanomedicine research and accelerate your work in targeted cancer therapies.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.